Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome
Authors
Keywords
Ovarian cancer, Human genetics, Platinum, Oligonucleotides, Surgical and invasive medical procedures, Transcription factors, Gene amplification, Mouse models
Journal
PLoS One
Volume 7, Issue 2, Pages e30996
Publisher
Public Library of Science (PLoS)
Online
2012-02-16
DOI
10.1371/journal.pone.0030996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival
- (2015) Adam Clauss et al. NEOPLASIA
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Chemosensitization Screen Identifies TP53RK, a Kinase that Restrains Apoptosis after Mitotic Stress
- (2010) D. Peterson et al. CANCER RESEARCH
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
- (2009) Meng Li et al. BMC Medical Genomics
- High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors
- (2009) Peter M Haverty et al. BMC Medical Genomics
- Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas
- (2009) K.-T. Kuo et al. CANCER RESEARCH
- Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicatesZEB2in tumor progression and prognosis
- (2009) Kosuke Yoshihara et al. CANCER SCIENCE
- Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
- (2009) A. Berchuck et al. CLINICAL CANCER RESEARCH
- Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
- (2009) D. Etemadmoghadam et al. CLINICAL CANCER RESEARCH
- Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis
- (2009) Kylie L. Gorringe et al. GENES CHROMOSOMES & CANCER
- Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study
- (2009) John Farley et al. GYNECOLOGIC ONCOLOGY
- Genomic Profiling of Atypical Meningiomas Associates Gain of 1q With Poor Clinical Outcome
- (2009) Darlene Gabeau-Lacet et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
- (2009) Woong Ju et al. ONCOLOGY RESEARCH
- Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer
- (2009) Biaoyang Lin et al. Proteomics Clinical Applications
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
- Better translation from bench to bedside: Breakthroughs in the individualized treatment of cancer
- (2008) Carolyn Straehle et al. CRITICAL CARE MEDICINE
- New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents
- (2008) Phuong Dinh et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- ID1, Inhibitor of Differentiation/DNA Binding, Is an Effector of the p53-dependent DNA Damage Response Pathway
- (2008) Yingjuan Qian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Early Events in the Pathogenesis of Epithelial Ovarian Cancer
- (2008) Charles N. Landen et al. JOURNAL OF CLINICAL ONCOLOGY
- Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
- (2008) William M. Merritt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
- (2008) J. E. Chipuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization
- (2008) Donatella Caserta et al. Molecular Cytogenetics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started